全文获取类型
收费全文 | 2386352篇 |
免费 | 168279篇 |
国内免费 | 4469篇 |
专业分类
耳鼻咽喉 | 35197篇 |
儿科学 | 75479篇 |
妇产科学 | 69701篇 |
基础医学 | 340659篇 |
口腔科学 | 69889篇 |
临床医学 | 202614篇 |
内科学 | 464655篇 |
皮肤病学 | 52074篇 |
神经病学 | 187900篇 |
特种医学 | 93765篇 |
外国民族医学 | 778篇 |
外科学 | 369847篇 |
综合类 | 53050篇 |
现状与发展 | 7篇 |
一般理论 | 711篇 |
预防医学 | 170933篇 |
眼科学 | 56286篇 |
药学 | 181183篇 |
5篇 | |
中国医学 | 4989篇 |
肿瘤学 | 129378篇 |
出版年
2018年 | 21630篇 |
2015年 | 21457篇 |
2014年 | 29847篇 |
2013年 | 45706篇 |
2012年 | 60945篇 |
2011年 | 65059篇 |
2010年 | 38657篇 |
2009年 | 36841篇 |
2008年 | 62890篇 |
2007年 | 68413篇 |
2006年 | 69391篇 |
2005年 | 67756篇 |
2004年 | 65498篇 |
2003年 | 63590篇 |
2002年 | 62733篇 |
2001年 | 109036篇 |
2000年 | 112212篇 |
1999年 | 95305篇 |
1998年 | 26302篇 |
1997年 | 23801篇 |
1996年 | 23464篇 |
1995年 | 22162篇 |
1994年 | 20988篇 |
1993年 | 19311篇 |
1992年 | 75677篇 |
1991年 | 73975篇 |
1990年 | 72862篇 |
1989年 | 71113篇 |
1988年 | 66267篇 |
1987年 | 65113篇 |
1986年 | 62213篇 |
1985年 | 59247篇 |
1984年 | 44374篇 |
1983年 | 38103篇 |
1982年 | 22756篇 |
1981年 | 20436篇 |
1979年 | 42373篇 |
1978年 | 30088篇 |
1977年 | 26041篇 |
1976年 | 24083篇 |
1975年 | 26946篇 |
1974年 | 31897篇 |
1973年 | 30876篇 |
1972年 | 29562篇 |
1971年 | 27545篇 |
1970年 | 25859篇 |
1969年 | 24979篇 |
1968年 | 23481篇 |
1967年 | 20798篇 |
1966年 | 19437篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
982.
983.
PTH has diverse effects on bone metabolism: anabolic when given intermittently, catabolic when given continuously. The cellular
mechanisms underlying the varying target cell response are not clear yet. PTH induces RGS-2, a member of the Regulator of
G-protein Signaling protein family, via cAMP/PKA, and inactivates PKC-mediated signaling. To investigate intracellular signaling
pathways with different PTH concentration-time patterns, we treated UMR 106-01 osteoblast-like cells in a perfusion system.
PTH was administered intermittently (4 min/h, 10−7 M) or continuously at an equivalent cumulative dose (6.6 × 10−9 M). cAMP was measured using radioimmunoassay, mRNA levels using real-time rtPCR and ribonuclease protection assay, and protein
levels using Western immunoblotting. A single PTH pulse transiently increased cAMP levels by 2000% ± 1200%. In contrast to
continuous PTH exposure, cAMP induction remained unchanged with intermittent PTH, ruling out desensitization of the PTH receptor.
In continuously perfused cells, RGS-2 abundance was three to five times higher than in cells intermittently exposed to PTH
for up to 12 h. MKP-1 and -3 were significantly less induced with pulsatile PTH; exposure-mode-dependent differences in MMP-13
and IGFBP-5 were small. Pulsatile but not continuous PTH administration prevents PTHrP receptor desensitization and accumulation
of RGS-2 in osteoblasts, which should preserve PKC-dependent signaling. 相似文献
984.
985.
A case of untreated fusarial onychomycosis leading to serious consequences is reported. Fusarium solani is a widespread fungus and an occasional human pathogen. It usually invades rapidly in immunocompromised hosts, and often results in a poor outcome despite treatment. We report a woman with diabetes mellitus who had untreated fusarial infection of the nails, which developed into subcutaneous fusariosis, superinfected by bacteria, and then evolved into osteomyelitis that subsequently resulted in septic shock. Early management of mycotic nails in immunocompromised hosts is crucial to prevent life‐threatening disease. 相似文献
986.
987.
988.
L.A. Fischer T. Menné C. Avnstorp G.B. Kasting† J.D. Johansen† 《The British journal of dermatology》2009,161(3):560-567
Background Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) is a synthetic fragrance ingredient. Case reports of allergy to HICC appeared in the 1980s, and HICC has recently been included in the European baseline series. Human elicitation dose–response studies performed with different allergens have shown a significant relationship between the patch-test threshold and the repeated open application test (ROAT) threshold, which mimics some real-life exposure situations. Fragrance ingredients are special as significant amounts of allergen may evaporate from the skin.
Objectives The study aimed to investigate the relationship between elicitation threshold doses at the patch test and the ROAT, using HICC as the allergen. The expected evaporation rate was calculated.
Materials and methods Seventeen HICC-allergic persons were tested with a dilution series of HICC in a patch test and a ROAT (duration up to 21 days). Seventeen persons with no HICC allergy were included as control group for the ROAT.
Results The response frequency to the ROAT (in μg HICC cm−2 per application) was significantly higher than the response frequency to the patch test at one of the tested doses. Furthermore the response rate to the accumulated ROAT dose was significantly lower at half of the doses compared with the patch test. The evaporation rate of HICC was calculated to be 72% over a 24-h period.
Conclusions The ROAT threshold in dose per area per application is lower than the patch test threshold; furthermore the accumulated ROAT threshold is higher than the patch test threshold, which can probably be explained by the evaporation of HICC from the skin in the open test. 相似文献
Objectives The study aimed to investigate the relationship between elicitation threshold doses at the patch test and the ROAT, using HICC as the allergen. The expected evaporation rate was calculated.
Materials and methods Seventeen HICC-allergic persons were tested with a dilution series of HICC in a patch test and a ROAT (duration up to 21 days). Seventeen persons with no HICC allergy were included as control group for the ROAT.
Results The response frequency to the ROAT (in μg HICC cm
Conclusions The ROAT threshold in dose per area per application is lower than the patch test threshold; furthermore the accumulated ROAT threshold is higher than the patch test threshold, which can probably be explained by the evaporation of HICC from the skin in the open test. 相似文献
989.
G Gaitanis K Nomikos E Vava EC Alexopoulos ID Bassukas 《Journal of the European Academy of Dermatology and Venereology》2009,23(12):1427-1431
Background/aim Theoretical considerations support the combination of cryosurgery and topical imiquimod to treat basal cell carcinomas (BCC). The aim of the present study was to test the feasibility and efficacy of 'cryosurgery during continued imiquimod application' ('immunocryosurgery') to treat 'high-risk-for-recurrence' BCCs.
Methods Thirteen patients with 21 biopsy-proven tumours (4 of 21 relapses after prior surgery) were included. After 2–5 weeks (median, 3) of daily 5% imiquimod cream application, the tumours were treated by liquid N2 cryosurgery (spray, two cycles, 10–20 s) and imiquimod was continued for additional 2–12 weeks (median, 4). The outcome after at least 18 months of follow-up (18–24 months) is currently reported.
Results Nineteen of 21 tumours responded promptly to immunocryosurgery; two tumours required additional treatment cycles to clear. Thus, the clinical clearance rate was 100%. Only 1 of 21(5%) tumour relapsed after at least 18 months of follow-up (cumulative efficacy: 95%).
Conclusions 'Immunocryosurgery' is a promising non-surgical combination modality to treat 'high-risk-for-recurrence BCCs'. Initial evidence is suggestive of an at least additive effect of the two combined modalities. Further studies comparing immunocryosurgery directly with cryosurgery and imiquimod monotherapies will confirm the reported results. 相似文献
Methods Thirteen patients with 21 biopsy-proven tumours (4 of 21 relapses after prior surgery) were included. After 2–5 weeks (median, 3) of daily 5% imiquimod cream application, the tumours were treated by liquid N
Results Nineteen of 21 tumours responded promptly to immunocryosurgery; two tumours required additional treatment cycles to clear. Thus, the clinical clearance rate was 100%. Only 1 of 21(5%) tumour relapsed after at least 18 months of follow-up (cumulative efficacy: 95%).
Conclusions 'Immunocryosurgery' is a promising non-surgical combination modality to treat 'high-risk-for-recurrence BCCs'. Initial evidence is suggestive of an at least additive effect of the two combined modalities. Further studies comparing immunocryosurgery directly with cryosurgery and imiquimod monotherapies will confirm the reported results. 相似文献
990.